Loading...

Purified anti-mouse CD16/32 Antibody

Pricing & Availability
Clone
93 (See other available formats)
Regulatory Status
RUO
Other Names
Fcγ R III/II, Ly-17
Isotype
Rat IgG2a, λ
Ave. Rating
Submit a Review
Product Citations
publications
93_purified_051906
C57BL/6 mouse splenocytes stained with purified 93, followed by anti-rat IgGs FITC
  • 93_purified_051906
    C57BL/6 mouse splenocytes stained with purified 93, followed by anti-rat IgGs FITC
Compare all formats
Cat # Size Price Quantity Check Availability Save
101301 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101302 500 µg 92€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD16 is low affinity IgG Fc receptor III (FcR III) and CD32 is FcR II. CD16/CD32 are expressed on B cells, monocytes/macrophages, NK cells, granulocytes, mast cells, and dendritic cells. The Fc receptors bind antibody-antigen immune complexes and mediate adaptive immune responses.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Sorted pre-B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD16/32 antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IP, Block - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 93 can be used for blocking of CD16/CD32 interactions with the Fc domain of immunoglobulins, but is not the same clone as 2.4G2.

The 93 mAb is specific to the common epitope of CD16/CD32. Additional reported applications (for the relevant formats) include: immunoprecipitation1 and blocking of Fc-mediated reactions in functional studies2,4,23. It is useful for blocking non-specific binding of immunoglobulin to Fc receptors. For blocking of Fc receptors in flow cytometric analysis, pre-incubate the cells with purified anti-CD16/CD32 antibody (=1.0 µg per 106 cells in 100 µL volume) for 5-10 minutes on ice prior to immunostaining. For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 101330) (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered).

Application References

(PubMed link indicates BioLegend citation)
  1. Personal communication (IP)
  2. Oliver AM, et al. 1999. Hybridoma 18:113. (Block)
  3. Brummel R and Lenert P. 2005. J. Immunol. 174:2429.
  4. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (Block)
  5. Clements JL, et al. 2006. J. Immunol. 177:905.
  6. Mohamed W, et al. 2010. Infect Immun. 78:3306. PubMed
  7. Ouchi T, et al. 2011. J. Exp Med. 208:2607. PubMed
  8. Kmieciak M, et al. 2011. J. Vis. Exp. 47:2381. PubMed
  9. Yamazaki S, et al. 2012. PLoS One. 7:e51665. PubMed
  10. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  11. Azuma M, et al. 2012. Oncoimmunology. 1:581. PubMed
  12. Koon HW, et al. 2013. J. Vis. Exp. 68:4208. PubMed
  13. Hegde VL, et al. 2013. J Biol Chem. 288:36810. PubMed
  14. Huang J, et al. 2013. J. Immunol Methods. 387:254. PubMed
  15. Dutow P, et al. 2014. J Infect Dis. PubMed
  16. Fan Y, et al. 2014. J Exp Med. 211:313. PubMed
  17. Huang HN, et al. 2014. Antimicrob Agents Chemother. 58:1538. PubMed
  18. Takei S, et al. 2014. Vaccine. 32:3066. PubMed
  19. Richardson ML, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
  20. Cekanaviciute E, et al. 2014. J Immunol. 193:139. PubMed
  21. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  22. Everad A, et al. 2014. Nat Commun. 5:5648. PubMed
  23. Cenci E, et al. 2006. J. Leuko. Biol. 79(1):40-5. (Block)
Product Citations
  1. Lee J, et al. 2015. Hum Reprod. 10.1093/humrep/dev222. PubMed
  2. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  3. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  4. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  5. Park E, et al. 2021. Journal of Neuroscience Research. . PubMed
  6. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  7. Kosti P, et al. 2021. Cell Reports Medicine. 2(4):100227. PubMed
  8. Barkaway A, et al. 2021. Immunity. . PubMed
  9. Sade-Feldman M,et al. 2017. Nat Commun.. 10.1038/s41467-017-01062-w. PubMed
  10. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  11. Gan T, et al. 2019. Front Microbiol. 9:3174. PubMed
  12. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  13. Fomin ME, et al. 2017. Cell Med. 0.45625. PubMed
  14. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  15. Filippini D, et al. 2019. Sci Rep. 9:12286. PubMed
  16. Flamar AL, et al. 2020. Immunity. 52(4):606-619.e6.. PubMed
  17. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  18. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  19. Foster A, et al. 2021. EBioMedicine. 71:103571. PubMed
  20. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  21. Rajagopalan A, et al. 2021. Cell Rep Methods. 1:. PubMed
  22. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  23. Van Braeckel-Budimir N, et al. 2021. J Immunother Cancer. 9:. PubMed
  24. Wang Z, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  25. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  26. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  27. Cerrato G, et al. 2021. Cell Death Differ. 28:1733. PubMed
  28. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  29. Liu C, et al. 2022. Nat Nanotechnol. 17:531. PubMed
  30. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  31. Wong Fok Lung T, et al. 2020. Nat Microbiol. 141:5. PubMed
  32. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  33. Benitez AA, et al. 2020. Commun Biol. 0.371527778. PubMed
  34. Castoldi Â, et al. 2020. Nat Commun. 3.310416667. PubMed
  35. Mevel R, et al. 2020. eLife. 9:00. PubMed
  36. Fan Y, et al. 2014. J Exp Med. 211:313. PubMed
  37. Berry CT, et al. 2020. Cell Reports. 31(2):107474.. PubMed
  38. Rendeiro AF, et al. 2020. Nat Commun. 11:577. PubMed
  39. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  40. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  41. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  42. Zou B, et al. 2017. PLoS Pathogens. 13(6):e1006436. PubMed
  43. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  44. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  45. Yu Y, et al. 2022. iScience. 25:105004. PubMed
  46. Huang Y, et al. 2021. Nat Immunol. 22:586. PubMed
  47. MacLean M, et al. 2022. Commun Biol. 5:177. PubMed
  48. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  49. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  50. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  51. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  52. Morris MG, et al. 2020. Comp Med. 70:336. PubMed
  53. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  54. Tan H,et al. 2017. Mucosal Immunol. . 10.1038/mi.2017.89. PubMed
  55. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  56. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  57. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
  58. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  59. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  60. Goel S, et al. 2017. Nature. 548:471. PubMed
  61. Matsui S, et al. 2018. Am J Pathol. 188:2059. PubMed
  62. Bhatia D, et al. 2019. JCI Insight. 4:e132826. PubMed
  63. Noh JR, et al. 2018. Sci Rep. 8:15222. PubMed
  64. Flores M, et al. 2008. FASEB J. 3.459027778. PubMed
  65. Tong J, et al. 2011. J Immunol. 186:3686. PubMed
  66. Martos-Rus C, et al. 2021. Sci Rep. 11:2974. PubMed
  67. Liu P, et al. 2021. Front Med (Lausanne). 8:625130. PubMed
  68. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  69. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  70. Khamissi FZ, et al. 2022. Sci Adv. 8:eabm5900. PubMed
  71. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  72. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  73. Feng J, et al. 2021. iScience. 24:103004. PubMed
  74. Wu L, et al. 2022. Front Immunol. 13:860761. PubMed
  75. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  76. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  77. Clark AL, et al. 2021. Diabetes Obesity and Metabolism. :. PubMed
  78. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  79. Yang SB, et al. 2021. Cancers (Basel). 13:00. PubMed
  80. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  81. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  82. Azuma M, et al. 2012. Oncoimmunology. 1:581. PubMed
  83. Yamazaki S, et al. 2012. PLoS One. 7:e51665. PubMed
  84. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  85. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  86. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  87. Gawden‐Bone CM et al. 2018. Immunity. 49(3):427-437 . PubMed
  88. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  89. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  90. Diao L, et al. 2022. iScience. 25:105511. PubMed
  91. Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed
  92. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  93. Sun SJ, et al. 2022. Commun Biol. 5:867. PubMed
  94. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  95. Roberto Raúl SG, et al. 2022. Breast Cancer (Auckl). 16:11782234211065154. PubMed
  96. Matthias J, et al. 2020. J Clin Invest. 130:4587. PubMed
  97. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  98. Liang F, et al. 2021. Front Immunol. 12:658715. PubMed
  99. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  100. Hazama D, et al. 2020. Cell Chemical Biology. 27(9):1181-1191.e7. PubMed
  101. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  102. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  103. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  104. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  105. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  106. Godbersen-Palmer C, et al. 2020. J Immunol. 204:2973. PubMed
  107. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  108. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  109. Fiala GJ, et al. 2019. J Immunol. 203:569. PubMed
  110. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  111. Kitashima DY, et al. 2018. EBioMedicine. 27:293. PubMed
  112. Li Y, et al. 2018. J Immunol. 201:2910. PubMed
  113. Carlson P, et al. 2019. Nat Cell Biol. 21:238. PubMed
  114. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  115. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  116. Liu D, et al. 2021. JCI Insight. 6:. PubMed
  117. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  118. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  119. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  120. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  121. Tal MC, et al. 2020. MBio. 11:00. PubMed
  122. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  123. Kovacs L, et al. 2020. PLoS One. 15:e0240455. PubMed
  124. Vackova J, et al. 2020. Int J Mol Sci. 21:00. PubMed
  125. Terrazas LI, et al. 2005. Int J Parasit. 35:1349. PubMed
  126. Bhattacherjee A, et al. 2019. Commun Biol. 2:450. PubMed
  127. Lieschke S, et al. 2019. Cells. 0.420833333. PubMed
  128. Sereni L, et al. 2018. J Allergy Clin Immunol. 142:1272. PubMed
  129. Fransen F, et al. 2017. Front Immunol. 1.295138889. PubMed
  130. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  131. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  132. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  133. Ma J, et al. 2021. Aging (Albany NY). 13:7211. PubMed
  134. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  135. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  136. Cheng XS, et al. 2020. J Cell Mol Med. 24:8391. PubMed
  137. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  138. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  139. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  140. Fiaturi N, et al. 2018. J Cell Commun Signal. 314:L127. PubMed
  141. Barajas‐Mora EM et al. 2018. Molecular cell. 73(1):48-60 . PubMed
  142. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  143. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  144. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  145. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  146. Barger SR, et al. 2019. Nat Commun. 10:1249. PubMed
  147. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  148. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  149. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  150. Russell SL, et al. 2019. Cell Rep. 29:3564. PubMed
  151. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  152. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  153. Damle SR, et al. 2018. Allergy. 73:125. PubMed
  154. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  155. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  156. Sheller-Miller S, et al. 2021. Sci Adv. 7:. PubMed
  157. Mao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  158. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  159. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  160. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  161. Menzel L, et al. 2022. STAR Protoc. 3:101267. PubMed
  162. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  163. Flommersfeld S, et al. 2021. Immunity. :. PubMed
  164. Wong HS, et al. 2021. Cell. . PubMed
  165. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  166. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  167. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  168. MacConmara M, et al. 2011. J Leukoc Biol. 89:137. PubMed
  169. Cassidy LD, et al. 2018. Autophagy. 1.455555556. PubMed
  170. Fransen F, et al. 2017. Front Immunol. 8:154. PubMed
  171. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  172. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  173. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  174. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  175. Go MJ, et al. 2018. Mol Med Rep. 13:e0194423. PubMed
  176. McGrath-Morrow S, et al. 2017. Cytokine. 10.1016/j.cyto.2017.06.002. PubMed
  177. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  178. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  179. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  180. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  181. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  182. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  183. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  184. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  185. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  186. Baasch S, et al. 2021. Cell. . PubMed
  187. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  188. Zheng J, et al. 2020. bioRxiv. . PubMed
  189. Csóka B, et al. 2018. JCI Insight. 38:200. PubMed
  190. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  191. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  192. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  193. Hashimoto M, et al. 2019. FASEB J. 33:8069. PubMed
  194. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  195. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  196. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  197. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  198. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  199. Hong CH, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:925. PubMed
  200. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  201. Hubbard JJ, et al. 2020. J Exp Med. :217. PubMed
  202. Xu S, et al. 2021. Immunity. . PubMed
  203. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  204. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  205. Duvigneau S, et al. 2016. Sci Rep. 6:37045. PubMed
  206. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  207. Moon H, et al. 2020. Nat Commun. 4.270138889. PubMed
  208. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  209. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  210. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  211. Roy K, et al. 2019. Immunity. 50:616. PubMed
  212. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  213. De Santi C, et al. 2022. Mol Ther Nucleic Acids. 29:643. PubMed
  214. Pereira M, et al. 2022. Cell Rep. 40:111225. PubMed
  215. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  216. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  217. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  218. Welte T, et al. 2021. iScience. 24:103349. PubMed
  219. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  220. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  221. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  222. Huang H, et al. 2014. Antimicrob Agents Chemother. 58:1538. PubMed
  223. Lehmann GL, et al. 2020. J Exp Med. 217:00:00. PubMed
  224. Zhao L, et al. 2020. EBioMedicine. 60:103020. PubMed
  225. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  226. Matsumoto K, et al. 2017. PLoS One. 12(6):e0175406. PubMed
  227. Sauma D, et al. 2017. Immunol Res. 10.1007/s12026-017-8936-9. PubMed
  228. Gil-Pulido J, et al. 2017. PLoS One.. 10.1371/journal.pone.0181947. PubMed
  229. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  230. Chen JC, et al. 2018. Front Immunol. 0.665277778. PubMed
  231. Peng L, et al. 2019. Mol Med Rep. 19:2876. PubMed
  232. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  233. Yan W, et al. 2021. Front Med (Lausanne). 8:752223. PubMed
  234. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  235. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  236. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  237. Sundararaj K, et al. 2021. Immunology. 162:418. PubMed
  238. Jeong M, et al. 2022. JCI Insight. 7:. PubMed
  239. Zheng J, et al. 2020. Nature. . PubMed
  240. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  241. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  242. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  243. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  244. Siggs O, et al. 2016. Proc Natl Acad Sci U S A. 113: 3706 - 3715. PubMed
  245. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  246. Cekanaviciute E, et al. 2014. J Immunol. 193:139. PubMed
  247. Hegde V, et al. 2013. J Biol Chem. 288:36810. PubMed
  248. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  249. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  250. Chu A, et al. 2021. J Reprod Immunol. 145:103309. PubMed
  251. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  252. Moon S, et al. 2021. J Exp Med. 218:. PubMed
  253. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  254. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  255. Huang BR, et al. 2020. Int J Mol Sci. 21:00. PubMed
  256. Lindborg JA, et al. 2021. Cell Reports. 34(9):108777. PubMed
  257. Ahn D, et al. 2021. Cell Reports. 35(9):109196. PubMed
  258. Enomoto D, et al. 2017. PLoS One.. 10.1371/journal.pone.0183584. PubMed
  259. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  260. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  261. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  262. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  263. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
  264. Li B, et al. 2019. Oncol Rep. 41:608. PubMed
  265. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  266. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  267. Akk A, et al. 2019. Mol Immunol. 114:629. PubMed
  268. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  269. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  270. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  271. Blanchard L, et al. 2022. STAR Protoc. 3:101444. PubMed
  272. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  273. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  274. Vilcaes AA, et al. 2020. Int J Mol Sci. :21. PubMed
  275. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  276. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  277. Lehmann ML, et al. 2020. Brain Behav Immun. 88:735. PubMed
  278. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  279. Takei S, et al. 2014. Vaccine. 32:3066. PubMed
  280. Constantinides M, et al. 2011. J Immunol. 187:309. PubMed
  281. Lenert R 2005. J Immunol. 174:2429. PubMed
  282. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  283. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  284. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  285. Sanchez M et al. 2017. Cell host & microbe. 22(4):543-551 . PubMed
  286. Shibamoto M, et al. 2019. Int Heart J. 60:944. PubMed
  287. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  288. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  289. Saveljeva S, et al. 2022. Cell Metab. 34:106. PubMed
  290. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  291. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  292. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  293. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  294. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  295. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  296. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  297. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  298. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  299. Tellechea M, et al. 2018. J Immunol. 200:305. PubMed
  300. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  301. Lyle C, et al. 2019. Sci Rep. 9:20257. PubMed
  302. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  303. Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
  304. Kolter J, et al. 2020. Immunity. 50(6):1482-1497. PubMed
  305. Nakav S, et al. 2009. Nephrol Dial Transplant. 25:931. PubMed
  306. Miranda-Hernandez S, et al. 2011. J Immunol. 187:791. PubMed
  307. Bi J, et al. 2022. Front Microbiol. 13:927122. PubMed
  308. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  309. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  310. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  311. Saxena M, et al. 2020. Cancer Res. 80:3631. PubMed
  312. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  313. Ouchi T, et al. 2011. J Exp Med. 208:2607. PubMed
  314. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  315. Forster R, et al. 2019. FASEB J. 33:11210. PubMed
  316. Heinen A, et al. 2019. Mol Ther. 27:46:00. PubMed
  317. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  318. William M, et al. 2018. J Immunol. 200:4102. PubMed
  319. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  320. Miura Y et al. 2018. eLife. 7 pii: e36572. PubMed
  321. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  322. Alshetaiwi H, et al. 2020. Methods Mol Biol. 2236:177. PubMed
  323. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  324. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  325. Lee SA, et al. 2021. Cells. 10:. PubMed
  326. Chida K, et al. 2021. Biol Pharm Bull. 44:1551. PubMed
  327. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  328. Howe C, et al. 2016. Sci Rep. 6:28699. PubMed
  329. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  330. Senatus L, et al. 2020. JCI Insight. 5:00. PubMed
  331. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  332. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  333. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  334. Freeman SA et al. 2018. Cell. 172(1-2):305-317 . PubMed
  335. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  336. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  337. Rojo R, et al. 2019. Nat Commun. 10:3215. PubMed
  338. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  339. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  340. Hong JP, et al. 2020. Cell Reports Medicine. 1(3):100035. PubMed
  341. Clements J, et al. 2006. J Immunol. 177:905. PubMed
  342. Sakurai Y, et al. 2021. Pharmaceutics. 13:. PubMed
  343. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  344. Magaletta ME, et al. 2022. Nat Commun. 13:457. PubMed
  345. Tzeng TT, et al. 2022. NPJ Vaccines. 7:60. PubMed
  346. Qiu Z, et al. 2020. Cancer Genet. 245:6. PubMed
  347. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  348. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  349. Luo X, et al. 2021. Neuron. 109:2691. PubMed
  350. McDonald MM, et al. 2021. Cell. 184(5):1330-1347.e13. PubMed
  351. Alam MM, et al. 2021. eneuro. 8(1):. PubMed
  352. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  353. Kim K, et al. 2015. Infect Immun . 83:1150. PubMed
  354. Penzo M, et al. 2010. J Immunol. 184:4497. PubMed
  355. Mehrpouya-Bahrami P, et al. 2019. J Biol Chem. 294:7669. PubMed
  356. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  357. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  358. Sivaram N, et al. 2019. J Clin Invest. 130. PubMed
  359. Litwinoff EMS, et al. 2017. Obes Res Clin Pract. 12:174. PubMed
  360. Burl RB et al. 2018. Cell metabolism. 28(2):300-309 . PubMed
  361. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  362. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  363. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  364. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  365. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  366. Melero I, et al. 2015. Cancer Res. 75:497. PubMed
  367. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  368. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  369. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  370. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  371. Lyons DO, et al. 2018. PLoS One. 13:e0207704. PubMed
  372. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  373. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  374. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  375. Sibler E, et al. 2021. Cells. 10:. PubMed
  376. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  377. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  378. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  379. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  380. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  381. Effern M, et al. 2020. Immunity. 53(3):564-580.e9. PubMed
  382. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  383. Richardson M, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
  384. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  385. Malinczak CA, et al. 2019. J Immunol. 10.4049/jimmunol.1900741. PubMed
  386. Wang X, et al. 2018. Front Immunol. 9:2615. PubMed
  387. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  388. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
RRID
AB_312800 (BioLegend Cat. No. 101301)
AB_312801 (BioLegend Cat. No. 101302)

Antigen Details

Structure
Ig superfamily, 40-60 kD
Distribution

B cells, monocyte/macrophages, NK cells, neutrophils, mast cells, dendritic cells

Function
Low affinity receptors for IgG
Ligand/Receptor
IgG
Cell Type
B cells, Dendritic cells, Macrophages, Mast cells, Monocytes, Neutrophils, NK cells
Biology Area
Immunology, Innate Immunity
Molecular Family
CD Molecules, Fc Receptors
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Unkeless JC. 1989. J. Clin. Invest. 83:355.
3. Qiu WQ, et al. 1990. Science 248:732.

Gene ID
14130 View all products for this Gene ID 14131 View all products for this Gene ID
UniProt
View information about CD16/32 on UniProt.org
Go To Top Version: 2    Revision Date: 01/23/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account